Persistent SARS-CoV-2 Infection in a Multiple Sclerosis Patient on Ocrelizumab: A Case Report

Raghava S Ambadapoodi1, Forest W Arnold2, Julia H Chariker3

  • 1Department of Neurology, University of Chicago Medical Center, Chicago, IL.

Research Square
|April 17, 2023
PubMed

Insights

A patient with multiple sclerosis (MS) on immunosuppressive therapy experienced persistent SARS-CoV-2 pneumonia. This case suggests that B-cell depletion therapy may impair viral clearance, leading to prolonged infections.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Neurology

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Ocrelizumab is an immunosuppressive monoclonal antibody used for MS treatment, targeting B cells.
  • Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection can cause pneumonia, posing risks to immunocompromised individuals.

Approach:

  • Case study of a 44-year-old female patient with MS treated with ocrelizumab.
  • Analysis of three hospitalizations for SARS-CoV-2 pneumonia over five months.
  • Viral sequencing from initial and final admissions to investigate infection persistence.

Key Points:

  • The patient suffered recurrent SARS-CoV-2 pneumonia despite treatment.
  • Viral sequencing indicated a single, persistent SARS-CoV-2 infection.
  • Immunosuppression from ocrelizumab is hypothesized to impede viral clearance.

Conclusions:

  • Persistent SARS-CoV-2 infection can occur in immunocompromised MS patients.
  • B-cell depletion therapy may compromise the immune system's ability to clear viral infections.
  • This case highlights potential risks associated with immunosuppressive treatments during viral pandemics.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
294
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
184
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
567